Abstract
Lead and cadmium nephropathy are rarely identified outside of the occupational setting, but the frequency of diagnosis may not reflect the prevalence of disease. Standardized diagnostic criteria for these renal diseases are not available and end-stage renal disease registries make no provision for their identification. Determining the etiology of chronic renal disease is difficult when causation is multifactorial and the attack rate is low. Moreover, the diagnostic effort may seem unjustified when the pathologic process is irreversible. It has long been suspected that environmental toxins produce renal damage but since long-term, low-level exposure leaves neither specific physical findings nor historical clues, physicians are usually unable to determine etiology in individual patients. Yet etiologic diagnosis is essential if prevention is to be achieved.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Wedeen RP, 1988: Occupational and environmental renal diseases. Curr Nephro 11: 65–106.
Kjellstrom T, 1986: Renal effects, in Cadmium and health: A toxicological and epidemiological appraisal. Friberg L, Elinder C-G, Kjellstrom T, Nordberg GF (eds). CRC Press, Boca Raton, Vol II, pp. 21–110.
Batuman V, Maesaka JK, Haddad B, Tepper E, Landy E, Wedeen RP, 1981: The role of lead in gout nephropathy. N Engl J Med 304: 520–3.
Ritz E, Mann J, Stoeppler M, 1988: Lead and the kidney, Adv Nephrol 17: 241–74.
Wedeen RP, 1984: Poison in the pot: The legacy of lead. Southern Illinois University Press, Carbondale.
Nicaud P, Lafitte A, Gross A, 1942: Les troubles de l’intoxication chronique par le cadmium. Arch Mal Prof Med 1: 192–202.
Scott R, Cunningham C, McLelland A, 1982: The importance of cadmium as a factor in calcified upper urinary tract stone disease: A prospective 7-year study. Br J Urol 54:584–9.
Kido T, Nogawa K, Ishizaki M, Honda R, Tsuritani I, Yamada Y, Nakagawa A, 1990: Long-term observation of serum creatinine and arterial blood pH in persons with cadmium-induced renal dysfunction, Arch Environ Health 45: 35–41.
Thun MJ, Osorio AM, Schober S, Hannon WH, Halperin W, 1989: Nephropathy in cadmium workers — Assessment of risk from airborne occupational cadmium exposure. Br J Ind Med 46: 689–697.
Roels HA, Lauwerys RR, Buchet JP, Bernard AM, Vos A, Oversteyns M, 1989: Health significance of cadmium-induced renal dysfunction: A five-year follow-up. Brit J Indust Med 46: 755–64.
Ahlgren L, Mattson S, 1981: Cadmium in man measured in vivo by X-ray fluorescence analysis. Phys Med Biol 26: 19–26.
Chettle DR, Franklin DM, Guthrie CJG, Scott MC, Somervaille LJ, 1987: In-vivo and in-vitro measurements of lead and cadmium. Biol Trace Element Res 13: 191–208.
Scott MC, Chettle DR, 1986: In-vivo elemental analysis in experimental medicine, Scand J Work Environ Health 12: 81–96.
Roels HA, Lauwerys RR, Buchet J-P, Bernard A, Chettle DR, Harvey TC, Al-Haddad IK, 1981: In vivo measurement of liver and kidney cadmium in workers exposed to this metal: Its significance with respect to cadmium in blood and urine. Environ Res 26: 217–40.
Jones KW, Schlidlovksy G, Williams FH, Wedeen RP, Batuman V, 1987: In vivo determination of tibial lead by K X-ray fluorescence with a Cd-109 source, in In vivo body composition studies. Ellis KJ, Yamamura S, Morgan WD (eds). Institute of Physical Sciences in Medicine, London, pp. 363–73.
Wedeen RP, Batuman V, Quinless F, Williams FH Jr, Bogden J, Schlidovsky G, Jones K, 1987: Lead nephropathy: In-vivo X-ray fluorescence (XRF) for assessing body lead stores, in In-vivo body composition studies. Ellis KJ, Yasumura SY, Morgen W (eds). The Institute of Physical Sciences in Medicine, London, pp. 357–362.
Morgan WD, Ryde SJS, Jones SJ, Wyatt RM, Hainsworth IR, Cobbold S, Evans CJ, Braithwaite RA, 1989: In-vivo measurements of cadmium and lead in occupationally-exposed workers and in an urban population. Biol Trace Elem Res 15: 1–14.
Skerfving S, Christoffersson J-O, Schutz A, Welinder H, Spang G, Ahlgren L, Mattson S, 1983: Biological monitoring, by in-vivo XRF measurements, of occupational exposure to lead, cadmium and mercuryhypertension with renal impairment. N Engl J Med 309: 17–21.
Van de Vyver FL, D’Haese PC, Visser WJ, Elsiviers MM, Knippenberg LJ, Lamberts LV, Wedeen RP, DeBroe ME, 1988: Bone lead in dialysis patients. Kidney Int 33: 601–7.
Cory-Shlecta D, Weiss B, Cox C, 1987: Mobilization and redistribution of lead over the course of calcium disodium ethylenediamine tetra-acetic acid chelation therapy. J. Pharm Exptl Ther 243: 804–13.
Fowler B, Silbergeld E (eds), 19xx: Proc int symposium on lead in bone, environ health perspect (in press).
Rosen JF, Markowitz ME, Bijur PE, Jenks ST, Weilopolski L, Kalef-Ezra JA, Slatkin DN, 1989: L-line X-ray fluorescence of cortical bone lead compared with CaNa2EDTA test in lead-toxic children: Public health implications, Proc Nat Acad Sci USA 86: 685–9.
Schidlovsky G, Jones K, Burger DE, Milder FL, Hu H, 19XX: Distribution of lead in human bone: II. Proton microprobe measurements. Proc int symposium on in vivo body composition studies, 20–23 June 1989, Plenum Press, Toronto (In press).
Wedeen RP, 1985: Blood lead levels, dietary calcium, and hypertension. Ann Int Med 102: 403–4.
Batuman V, Landy E, Maesaka JK, Wedeen RP, 1983: Contribution of lead to hypertension with renal impairment. N Engl J Med 309: 17–21.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Wedeen, R.P. (1991). Prevention of cadmium and lead nephropathy. In: de Broe, M.E., Verpooten, G.A. (eds) Prevention in nephrology. Developments in Nephrology, vol 28. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-3798-0_7
Download citation
DOI: https://doi.org/10.1007/978-94-011-3798-0_7
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-5690-8
Online ISBN: 978-94-011-3798-0
eBook Packages: Springer Book Archive